SHR8554 Injection

DRUG3 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd.

Conditions

Moderate to Severe Postoperative PainPain

Phase 1

A Pharmacokinetic Study of SHR8554 Injection in the Population With Renal Insufficiency and Healthy Participants

CompletedNCT07189962

Jiangsu HengRui Medicine Co., Ltd.Moderate to Severe Postoperative Pain

Start: 2022-09-20End: 2023-04-13Updated: 2025-09-24

Phase 2

A Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery

CompletedNCT05375305

Jiangsu HengRui Medicine Co., Ltd.Pain

Start: 2022-05-11End: 2023-10-19Updated: 2023-12-26

Phase 3

A Clinical Study of SHR8554 Injection for the Treatment of Pain After Abdominal Surgery.

CompletedNCT04766463

Jiangsu HengRui Medicine Co., Ltd.Pain

Start: 2021-03-03End: 2021-11-01Updated: 2022-07-06